This site is intended for healthcare professionals

BeiGene presents data at ESMO virtual congress 2020 on phase III trial of tislelizumab in first-line non-squamous non-small cell lung cancer.

Read time: 2 mins
Last updated:16th Mar 2021
Published:19th Sep 2020
Condition: Non Small Cell Lung Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest